Core Viewpoint - The stock prices of several companies, including Kesh Holdings, Bawei Holdings, and Yiyi Holdings, have seen significant increases, indicating positive market sentiment and potential investment opportunities in these firms [1] Company Performance - Kesh Holdings experienced a stock price increase of over 10% [1] - Bawei Holdings and Yiyi Holdings both saw their stock prices rise by more than 5% [1] - Other companies such as Shuiyang Holdings, Huaye Fragrance, Polaier, and Fulejia also showed upward trends in their stock prices [1]

Group 1 - The beauty care sector is experiencing active trading, with significant stock price increases for several companies [1] - Keshare Co. saw a rise of 5.5%, while Yiyi Co. increased by 4% [1] - Other companies such as Shuiyang Co., Bavi Co., Huaye Fragrance, and Proya also showed upward movement in their stock prices [1]

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [6][37]. Core Insights - The report highlights a robust performance in the beauty and personal care sector during the Double Eleven shopping festival, with significant sales growth across various platforms [4][28]. - The overall retail sales growth in October 2025 was 2.9%, surpassing market expectations, with notable increases in gold and jewelry sales, while categories like automotive and home appliances saw declines [3][24]. - The report emphasizes the strong performance of specific companies, such as Proya and Marubi, which achieved substantial sales growth during the Double Eleven event [4][31]. Summary by Sections Market Performance - During the week of November 10-14, 2025, the retail, social services, and beauty care sectors saw increases of 4.06%, 2.28%, and 3.75% respectively, ranking 3rd, 12th, and 4th among 31 primary industries [15][17]. Key Industry Data and News - In October 2025, retail sales grew by 2.9%, with jewelry sales increasing by 37.6%. In contrast, retail sales for home appliances and automotive categories declined by 14.6% and 6.6% respectively [3][24]. - The total retail sales for the first ten months of 2025 reached 41.22 trillion yuan, with a year-on-year growth of 4.28% [24]. Key Company Announcements - Marubi plans to issue H shares and apply for a listing on the Hong Kong Stock Exchange to enhance its capital strength and competitiveness [36]. - The founder of Yonghui Supermarket intends to reduce his shareholding, potentially affecting the company's stock performance [36]. Investment Recommendations - The report recommends focusing on companies such as Proya, Giant Bio, Marubi, Runben, and Chaohongji, which are positioned well within the beauty care and new consumption sectors [6][37].

Group 1: Stock Recommendations - Geely Automobile (175 HK) has a target price of 25.00, indicating a potential upside of 47% with a PE ratio of 9.50[5] - Luckin Coffee (LKNCY US) has a target price of 44.95, suggesting a potential upside of 12% with a PE ratio of 30.00[5] - Alibaba (BABA US) has a target price of 209.40, indicating a potential upside of 33% with a PE ratio of 22.50[5] Group 2: Market Performance - The basket of 24 long positions had an average return of -3.4%, while the MSCI China Index returned -0.8%[9] - Among the 24 stocks, only 5 outperformed the benchmark[9] Group 3: Analyst Ratings - New additions include companies like Bosideng (3998 HK) and Futu Holdings (FUTU US), both rated as "Buy"[6] - The report indicates a focus on sectors such as technology, insurance, and consumer goods, with multiple stocks receiving "Buy" ratings[5][6]

Investment Rating - The report maintains an "Overweight" rating for the retail industry [1] Core Insights - The 2025 Double Eleven sales period saw a total e-commerce sales of approximately 1,695 billion yuan, representing a year-on-year increase of 14.2%. The comprehensive e-commerce platforms accounted for 1,619.1 billion yuan, with a year-on-year growth of 12.3% [4][9] - Instant retail showed remarkable growth, with sales reaching 67 billion yuan during the Double Eleven period, marking a year-on-year increase of 138% [10][15] - Key product categories such as digital appliances, food and beverages, furniture, and pet products experienced significant growth, with pet sales reaching 9.2 billion yuan, up 59% year-on-year [15][16] Summary by Sections Weekly Industry Viewpoint - The Double Eleven sales period was extended, contributing to steady growth in total e-commerce sales. The sales period for 2025 was from October 7 to November 11, compared to October 14 to November 11 in 2024 [9] - Instant retail emerged as a highlight, with substantial growth compared to traditional e-commerce formats [10] Weekly Market Review - From November 10 to November 16, the Shenwan retail index increased by 4.06%, while the Shanghai Composite Index decreased by 0.18% [17] - Year-to-date performance shows the Shenwan retail index up by 8.43%, compared to a 19.06% increase in the Shanghai Composite Index [17][22] Company Valuation Table - The report includes a detailed valuation table for various companies in the retail sector, with specific metrics such as market capitalization and P/E ratios [24][25]

Group 1 - The beauty and personal care sector has shown a recovery in 2025, with the SW Beauty Index rebounding after a decline from 2022 to 2024, achieving a maximum increase of over 15% and becoming a key area in new consumption [3][9][10] - The cosmetics segment is characterized by intense competition among brands, with domestic brands making significant strides in R&D and distribution, while international brands are adopting localized strategies to regain market share [3][20][25] - The medical beauty market is transitioning from a blue ocean to a red ocean, with domestic companies expected to become major competitors by focusing on affordable and specialized products [3][19][24] Group 2 - The e-commerce operation sector is undergoing a transformation, with companies like RuYuchen and Shuiyang Co. leveraging brand incubation and AI to create new growth avenues [3][19] - Key investment recommendations include domestic brands with strong channel and brand matrices such as MaoGePing, ShangMei Co., and PoLaiYa, as well as companies in the medical beauty sector like AiMeiKe and LongZi Co. [3][19][24] - The report emphasizes the importance of brand matrix construction and product innovation in the cosmetics industry, with companies like ShangMei Co. and PoLaiYa leading the way [3][31][40] Group 3 - The skincare and makeup market is expected to enter a phase of consolidation, with strong brands likely to thrive while weaker ones may struggle [23][24] - The market share of domestic brands is increasing, with a notable decline in the market share of international brands, indicating a significant opportunity for domestic players [25][30] - The report highlights the importance of adapting to changing consumer preferences and channel dynamics, with a focus on online platforms and promotional strategies to enhance brand visibility [48][52][53]

Core Viewpoint - The company, Proya Cosmetics Co., Ltd., has submitted an application for the issuance of H-shares and listing on the Hong Kong Stock Exchange, which has been accepted by the China Securities Regulatory Commission (CSRC) [1][2]. Group 1 - The company submitted its application for H-share issuance and listing on October 30, 2025, and published the application materials on the Hong Kong Stock Exchange website [1]. - The application materials for the issuance and listing have been accepted by the CSRC, indicating progress in the regulatory process [1][2]. - The company is required to obtain approvals from various regulatory bodies, including the CSRC, the Hong Kong Securities and Futures Commission, and the Hong Kong Stock Exchange, which introduces uncertainty regarding the completion of the listing [2].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Insights - The company reported a revenue of 7.098 billion yuan for Q1-Q3 2025, representing a year-on-year growth of 1.9%. The net profit attributable to shareholders was 1.03 billion yuan, up 2.65% year-on-year. However, in Q3 alone, revenue decreased by 11.6% to 1.74 billion yuan, and net profit fell by 23.6% to 230 million yuan [2][4]. Revenue Analysis - In Q3 2025, the company experienced seasonal pressure on revenue, with skincare, beauty makeup, and hair care categories generating revenues of 1.32 billion, 240 million, and 180 million yuan respectively. The year-on-year growth rates were -20.4%, 0.9%, and 138% respectively. The main brand, focused on skincare, faced challenges, while the OR brand, focused on hair care, showed strong growth [10]. Profitability Analysis - The gross margin continued to improve, with a net profit margin of 13.1% in Q3, down 2.1 percentage points year-on-year. The gross margin increased by 3.96 percentage points to 74.7%, attributed to category structure optimization and cost reduction efforts. However, selling, administrative, research and development, and financial expense ratios increased by a total of 6.8 percentage points [10]. Investment Recommendations - Given the current challenges faced by the main brand and the increase in expense ratios, the company is experiencing temporary pressure on revenue and net profit. However, the main brand maintains a strong comparative advantage due to a well-rounded product matrix. The OR brand is expected to contribute additional growth in the future. The projected EPS for 2025-2027 is 3.97, 4.44, and 5.00 yuan per share respectively [10].

Investment Rating - The beauty and personal care industry is rated as "Recommended" [1] Core Insights - The overall market shows stable growth, with impressive performance in instant retail during the Double Eleven shopping festival, achieving a total e-commerce sales of 1,695 billion yuan, a year-on-year increase of 14.2% [2] - The beauty sector outperformed the overall e-commerce market, with skincare sales reaching 991 billion yuan and fragrance and makeup sales at 334 billion yuan, both showing double-digit growth [3] - Domestic brands are gaining strength, with notable performances from brands like Proya and Han Shu, while international luxury brands are also recovering [4][5] Summary by Sections Market Overview - The Double Eleven shopping festival saw a total e-commerce sales of 1,695 billion yuan, with a 14.2% year-on-year growth. Instant retail sales reached 67 billion yuan, marking a significant increase of 138.4% [2] Beauty Sector Performance - The beauty and skincare sales during Double Eleven reached 991 billion yuan, with fragrance and makeup sales at 334 billion yuan, both exceeding the overall market growth rate [3] Brand Analysis - On Tmall, domestic brands occupy five spots in the top 20 beauty brands, with Proya maintaining the top position. International brands like L'Oréal and Estée Lauder also showed improvements [4] - On Douyin, domestic brands hold five spots in the top 10 beauty brands, with Han Shu and Proya leading the rankings [5] Investment Recommendations - The report suggests focusing on brands with strong growth and performance certainty, such as MaoGeping and Marubi. Brands showing significant improvement include Shuiyang and Shanghai Jahwa, while companies with core technology and clear long-term trends like Juzibio are also recommended [6]

Group 1 - Yongtai Technology's wholly-owned subsidiary has received approval for trial production of a lithium battery additive project with an annual capacity of 5,000 tons, set to begin trial production [1] - Mengke Pharmaceutical has decided to terminate its plan to issue shares to a specific entity due to ongoing disagreements among major shareholders, which could impact the company's stable operations [1] - Anhui Construction's subsidiary has been approved to register and issue debt financing tools totaling 15 billion yuan, including 5 billion yuan in short-term financing notes and 10 billion yuan in medium-term notes [2] Group 2 - Koli'er plans to repurchase shares worth between 10 million and 20 million yuan, with a maximum repurchase price of 20.94 yuan per share, to implement an employee stock ownership plan [2] - Xinhua Pharmaceutical has received approval for the production of fumaric acid volnoral raw materials, which are used to treat gastroesophageal reflux disease [3] - Lianhuan Pharmaceutical has received approval for additional specifications of tadalafil tablets, expanding its product offerings for treating erectile dysfunction and benign prostatic hyperplasia [5] Group 3 - Greenland Holdings reported an increase of 1,834 lawsuits with a total amount of 6.587 billion yuan from October 21 to November 13, 2025 [7] - Lianke Technology plans to invest up to 600 million yuan of idle funds in low-risk financial products [8] - Yinglian Co. signed a strategic procurement contract for 5,000 million square meters of composite aluminum foil with a leading new energy technology company [10] Group 4 - China Eastern Airlines reported a 10.58% year-on-year increase in passenger turnover for October, with a capacity increase of 6.84% [12] - China National Airlines reported an 8.7% year-on-year increase in passenger turnover for October, with domestic and international capacity also showing growth [15] - Oupai Home plans to use 320 million yuan of idle funds to purchase structured deposits with expected annual yields between 0.65% and 2.50% [16] Group 5 - Tianwei Food has submitted H-share issuance application materials to the Hong Kong Stock Exchange, which have been accepted by the China Securities Regulatory Commission [18] - Guizhou Aviation plans to establish a subsidiary focused on the research, production, and market expansion of intelligent automotive components, with initial operating funds of 40 million yuan [20] - Daimai Co. plans to invest 100 million yuan to establish a wholly-owned subsidiary in Shanghai focused on robotics technology [22] Group 6 - Founder Securities has received approval to issue company bonds totaling up to 30 billion yuan [24] - Hengrui Medicine has received clinical trial approvals for multiple drugs, indicating ongoing research and development efforts [26] - Zhaojing Pharmaceutical's product ZG006 has received orphan drug designation from the FDA, providing various benefits for its development in the U.S. market [39]